THE EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF A SYNDROME OF KASABACH-MERRITT AT CHILDREN ON THE FIRST YEAR OF LIFE

Abstract


A solitary hemangioma with thrombocytopenia and general coagulation disorders is rather rare disease. There are definite difficulties in diagnostic and treatment of this disease. In this article we describe two clinical cases of Kasabach-Merritt syndrome diagnostic and treatment.

Full Text

Restricted Access

About the authors

P. V Tokarev

«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»; «Kazan State Medical University» of the Ministry of Public Health of the Russian Federation

420011, Kazan; 420012, Kazan

Rinat Akhmedullovich Saleev

«Kazan State Medical University» of the Ministry of Public Health of the Russian Federation

Email: rinat.saleev@gmail.com
420012, Kazan
Dr Med. Sci., Dean of Faculty of Dentistry of Kazan State Medical University Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of Russia, 420012, Kazan, Russia

A. V Shulaev

«Kazan State Medical University» of the Ministry of Public Health of the Russian Federation

420012, Kazan

L. V Plaksina

«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»

420011, Kazan

N. T Safin

«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»

420011, Kazan

References

  1. Поляев Ю.А., Постников С.С., Мыльников А.А., Гарбузов Р.В., Нарбутов А.Г., Шимановский Н.Л. Новые возможности в лечении инфантильных гемангиом с помощью пропранолола. Международный медицинский журнал. 2012; 2: 94-103.
  2. Leaute-Labreze C., Prey S., Ezzedine K. Infantile haemangioma: Part II. Risks, complications and treatment. J. Eur. Acad. Dermato.l Venerol. 2011; 25: 1254 - 60.
  3. Oak S.N., Viswanath K. Management of hemangioma in children. Indian J. Dermatol. Venerol. Leprol. 2006; 18 (72): 1-4.
  4. Zvulunov A., McCuaig C., Frieden I.J., et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr. Dermatol. 2011; 28 (2): 94-8.
  5. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008; 358 (24): 2649 - 51.
  6. Kilkline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr. Dermatol. 2008; 25: 168 - 73.
  7. Buckmiller L.M., Munsun. P.D., Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010; 120: 676 - 81.
  8. Stroch C. H., Hoeger P.H. Propranolol for infantile hemangiomas: insights into the molecular mechanisms of actions. Br. J. Dermatol. 2010; 163(2): 269 -74.
  9. Schiestl C., Neuhaus K. , Zoller S. et al. Efficacy and safety of propranolol at first - line treatment for infantile hemangiomas. Eur. J. Pediatr. 2011; 170 (4): 493 - 501.
  10. Leonardi-Bee J., Batta K., O’Brien C., Bath-Hextall F.J. Intervenous for infantile hemangiomas (strawberry birth marks) of the skin. Cochrane Database Syst Rev. 2011; (5): CD006545.

Statistics

Views

Abstract - 39

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2019 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies